Upswitch
Get startedStart as a business owner
Log In
  1. Home
  2. Companies
Upswitch

Knowing your worth is a right, not a privilege.

know it · build it strong · hand it on

Product

  • The Value Curve
  • Your workspace
  • Business Card
  • Pricing
  • Valuation methods
  • Capital gains tax 2026

Solutions

  • For business owners
  • For buyers
  • For Advisors
  • For banks & lenders
  • For private equity

Markets

  • Companies
  • European SME multiples
  • Multiples database

Company

  • Manifesto
  • Blog
  • Security

Legal

  • Privacy
  • Terms
Log in·See what could be weakening my business

Upswitch BV: Zetel: Tuinwijk ter Heide 69, 9050 Gentbrugge, België: Ondernemingsnr.: 1033.441.760-BTW: BE 1033.441.760-RPR Ondernemingsrechtbank Gent - hello@upswitch.app

© 2026 Upswitch

·

Made within Ghent, Belgium

LDW Farma
  • Financials
    • Public annual accounts

    LDW Farma financials

    A multi-period view of the public annual-account figures reported for LDW Farma, with comparable measures and links to available source documents.

    Company overview
    Registry number

    1007692319

    Fiscal coverage

    2024–2025

    Public sources

    cbso_bulk

    Data updated

    Jul 27, 2026

    Financial evidence

    Latest movements for LDW Farma

    2025 versus 2024

    Operating line
    €47,129

    +105.1%

    EBITDA
    €47,129

    +106.8%

    Total assets
    €71,475

    -8.2%

    Equity
    €38,553

    +238.5%

    EBITDA margin +100% · Equity ratio +53.9%

    Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

    Public company datasets

    Explore the underlying reports

    Valuation

    2 valuation checkpoints · 2024 to 2025 · Method family

    Open report
    Multi-year filings

    Filed annual accounts by fiscal year

    Public regulator-filed figures across 2 years.

    Source: NBB/CBSO
    Fiscal year
    Gross margin
    EBITDA
    Total assets
    Equity
    Filing
    202530 Sept 2025€47,129€47,129€71,475€38,553-
    202430 Sept 2024€22,984€22,794€77,899€11,388-
    Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.